Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 210

1.

Comparing astrocytic cell lines that are inhibitory or permissive for axon growth: the major axon-inhibitory proteoglycan is NG2.

Fidler PS, Schuette K, Asher RA, Dobbertin A, Thornton SR, Calle-Patino Y, Muir E, Levine JM, Geller HM, Rogers JH, Faissner A, Fawcett JW.

J Neurosci. 1999 Oct 15;19(20):8778-88.

3.

Increased axon regeneration in astrocytes grown in the presence of proteoglycan synthesis inhibitors.

Smith-Thomas LC, Stevens J, Fok-Seang J, Faissner A, Rogers JH, Fawcett JW.

J Cell Sci. 1995 Mar;108 ( Pt 3):1307-15.

4.

Limited growth of severed CNS axons after treatment of adult rat brain with hyaluronidase.

Moon LD, Asher RA, Fawcett JW.

J Neurosci Res. 2003 Jan 1;71(1):23-37.

PMID:
12478611
5.

Chondroitin 6-sulphate synthesis is up-regulated in injured CNS, induced by injury-related cytokines and enhanced in axon-growth inhibitory glia.

Properzi F, Carulli D, Asher RA, Muir E, Camargo LM, van Kuppevelt TH, ten Dam GB, Furukawa Y, Mikami T, Sugahara K, Toida T, Geller HM, Fawcett JW.

Eur J Neurosci. 2005 Jan;21(2):378-90.

PMID:
15673437
6.

Axon behaviour at Schwann cell - astrocyte boundaries: manipulation of axon signalling pathways and the neural adhesion molecule L1 can enable axons to cross.

Adcock KH, Brown DJ, Shearer MC, Shewan D, Schachner M, Smith GM, Geller HM, Fawcett JW.

Eur J Neurosci. 2004 Sep;20(6):1425-35.

PMID:
15355310
7.
8.
9.

Lesion-induced differential expression and cell association of Neurocan, Brevican, Versican V1 and V2 in the mouse dorsal root entry zone.

Beggah AT, Dours-Zimmermann MT, Barras FM, Brosius A, Zimmermann DR, Zurn AD.

Neuroscience. 2005;133(3):749-62.

PMID:
15896911
10.
12.

Astrocytes and axon regeneration in the central nervous system.

Fawcett J.

J Neurol. 1994 Dec;242(1 Suppl 1):S25-8. Review.

PMID:
7699404
13.

The astrocyte/meningeal cell interface is a barrier to neurite outgrowth which can be overcome by manipulation of inhibitory molecules or axonal signalling pathways.

Shearer MC, Niclou SP, Brown D, Asher RA, Holtmaat AJ, Levine JM, Verhaagen J, Fawcett JW.

Mol Cell Neurosci. 2003 Dec;24(4):913-25.

PMID:
14697658
14.

An analysis of astrocytic cell lines with different abilities to promote axon growth.

Fok-Seang J, Smith-Thomas LC, Meiners S, Muir E, Du JS, Housden E, Johnson AR, Faissner A, Geller HM, Keynes RJ, et al.

Brain Res. 1995 Aug 21;689(2):207-23.

PMID:
7583324
15.

Bovine CNS myelin contains neurite growth-inhibitory activity associated with chondroitin sulfate proteoglycans.

Niederöst BP, Zimmermann DR, Schwab ME, Bandtlow CE.

J Neurosci. 1999 Oct 15;19(20):8979-89.

16.
17.

Cells expressing the NG2 antigen contact nodes of Ranvier in adult CNS white matter.

Butt AM, Duncan A, Hornby MF, Kirvell SL, Hunter A, Levine JM, Berry M.

Glia. 1999 Mar;26(1):84-91.

PMID:
10088675
18.

Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells.

Asher RA, Morgenstern DA, Shearer MC, Adcock KH, Pesheva P, Fawcett JW.

J Neurosci. 2002 Mar 15;22(6):2225-36.

19.

Comparative screening of glial cell types reveals extracellular matrix that inhibits retinal axon growth in a chondroitinase ABC-resistant fashion.

Siddiqui S, Horvat-Broecker A, Faissner A.

Glia. 2009 Oct;57(13):1420-38. doi: 10.1002/glia.20860.

PMID:
19243018
20.

Inhibition of axon growth by oligodendrocyte precursor cells.

Chen ZJ, Ughrin Y, Levine JM.

Mol Cell Neurosci. 2002 May;20(1):125-39.

PMID:
12056844
Items per page

Supplemental Content

Support Center